1. Home
  2. FLGC vs CLDI Comparison

FLGC vs CLDI Comparison

Compare FLGC & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGC
  • CLDI
  • Stock Information
  • Founded
  • FLGC 2019
  • CLDI 2014
  • Country
  • FLGC United States
  • CLDI United States
  • Employees
  • FLGC N/A
  • CLDI N/A
  • Industry
  • FLGC Biotechnology: Pharmaceutical Preparations
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FLGC Health Care
  • CLDI Health Care
  • Exchange
  • FLGC Nasdaq
  • CLDI Nasdaq
  • Market Cap
  • FLGC 15.5M
  • CLDI 18.1M
  • IPO Year
  • FLGC 2021
  • CLDI N/A
  • Fundamental
  • Price
  • FLGC $1.05
  • CLDI $1.36
  • Analyst Decision
  • FLGC Strong Buy
  • CLDI Strong Buy
  • Analyst Count
  • FLGC 4
  • CLDI 3
  • Target Price
  • FLGC $5.67
  • CLDI $16.67
  • AVG Volume (30 Days)
  • FLGC 956.1K
  • CLDI 1.1M
  • Earning Date
  • FLGC 11-13-2024
  • CLDI 11-12-2024
  • Dividend Yield
  • FLGC N/A
  • CLDI N/A
  • EPS Growth
  • FLGC N/A
  • CLDI N/A
  • EPS
  • FLGC N/A
  • CLDI N/A
  • Revenue
  • FLGC $64,154,000.00
  • CLDI N/A
  • Revenue This Year
  • FLGC N/A
  • CLDI N/A
  • Revenue Next Year
  • FLGC $8.94
  • CLDI N/A
  • P/E Ratio
  • FLGC N/A
  • CLDI N/A
  • Revenue Growth
  • FLGC N/A
  • CLDI N/A
  • 52 Week Low
  • FLGC $0.75
  • CLDI $0.14
  • 52 Week High
  • FLGC $2.93
  • CLDI $3.89
  • Technical
  • Relative Strength Index (RSI)
  • FLGC 36.74
  • CLDI 35.60
  • Support Level
  • FLGC $1.60
  • CLDI $1.60
  • Resistance Level
  • FLGC $1.22
  • CLDI $2.17
  • Average True Range (ATR)
  • FLGC 0.20
  • CLDI 0.20
  • MACD
  • FLGC -0.08
  • CLDI -0.10
  • Stochastic Oscillator
  • FLGC 7.89
  • CLDI 10.00

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Share on Social Networks: